- Home
- KZIA vs AMIX Comparison
KZIA vs AMIX Comparison
Compare KZIA & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- AMIX
- Stock Information
- Founded
- KZIA 1994
- AMIX 2014
- Country
- KZIA Australia
- AMIX United States
- Employees
- KZIA N/A
- AMIX N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- AMIX
- Sector
- KZIA Health Care
- AMIX
- Exchange
- KZIA Nasdaq
- AMIX NYSE
- Market Cap
- KZIA 6.0M
- AMIX 5.5M
- IPO Year
- KZIA 1999
- AMIX N/A
- Fundamental
- Price
- KZIA $0.88
- AMIX $2.97
- Analyst Decision
- KZIA Strong Buy
- AMIX
- Analyst Count
- KZIA 2
- AMIX 0
- Target Price
- KZIA $11.50
- AMIX N/A
- AVG Volume (30 Days)
- KZIA 5.5M
- AMIX 57.5K
- Earning Date
- KZIA 03-26-2025
- AMIX 02-13-2025
- Dividend Yield
- KZIA N/A
- AMIX N/A
- EPS Growth
- KZIA N/A
- AMIX N/A
- EPS
- KZIA N/A
- AMIX N/A
- Revenue
- KZIA $1,655,324.00
- AMIX N/A
- Revenue This Year
- KZIA N/A
- AMIX N/A
- Revenue Next Year
- KZIA N/A
- AMIX N/A
- P/E Ratio
- KZIA N/A
- AMIX N/A
- Revenue Growth
- KZIA 248000.00
- AMIX N/A
- 52 Week Low
- KZIA $0.85
- AMIX $2.55
- 52 Week High
- KZIA $15.80
- AMIX $93.80
- Technical
- Relative Strength Index (RSI)
- KZIA 29.00
- AMIX 47.86
- Support Level
- KZIA $0.90
- AMIX $2.76
- Resistance Level
- KZIA $1.60
- AMIX $2.95
- Average True Range (ATR)
- KZIA 0.14
- AMIX 0.16
- MACD
- KZIA 0.02
- AMIX 0.08
- Stochastic Oscillator
- KZIA 4.00
- AMIX 72.83
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.